Get in on FSD Pharma Inc.’s (HUGE) buy-in window today!

FSD Pharma Inc. (NASDAQ: HUGE) stock jumped 6.67% on Monday to $1.60 against a previous-day closing price of $1.50. With 1.46 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.16 million shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $1.6799 whereas the lowest price it dropped to was $1.4700. The 52-week range on HUGE shows that it touched its highest point at $2.10 and its lowest point at $0.62 during that stretch. Beta for the stock currently stands at 0.86.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of HUGE was up-trending over the past week, with a rise of 24.03%, but this was up by 18.69% over a month. Three-month performance surged to 34.45% while six-month performance rose 9.59%. The stock gained 81.55% in the past year, while it has gained 102.94% so far this year. A look at the trailing 12-month EPS for HUGE yields -1.00 with Next year EPS estimates of -0.41. For the next quarter, that number is -0.14. This implies an EPS growth rate of 29.00% for this year and 37.90% for next year.

Float and Shares Shorts:

At present, 39.23 million HUGE shares are outstanding with a float of 30.24 million shares on hand for trading. On Aug 30, 2023, short shares totaled 0.32 million, which was 0.82% higher than short shares on Jul 30, 2023. In addition to Mr. Zeeshan Saeed as the firm’s Founder, CEO, Pres & Exec. Co-Chairman, Mr. Anthony John Durkacz serves as its Founder & Exec. Co-Chairman.

Institutional Ownership:

Through their ownership of 2.68% of HUGE’s outstanding shares, institutional investors have minority control over the company. Other institutions hold — of HUGE, in contrast to — held by mutual funds. Shares owned by individuals account for –. With a 1.68% stake in HUGE, the Horizons Psychedelic Stock Index is the largest stakeholder. A total of 655,215 shares are owned by the mutual fund manager. The AdvisorShares Psychedelics ETF, which owns about 0.74% of HUGE stock, is the second-largest Mutual Fund holder. It holds 288,037 shares valued at 0.37 million.

An Overview of Recent Financials:

Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Jun 29, 2023, HUGE reported revenue of $0.00 and operating income of -$7.87M. The EBITDA in the recently reported quarter was -$6.73M and diluted EPS was -$0.12.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for HUGE since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With HUGE analysts setting a high price target of $6.00 and a low target of $6.00, the average target price over the next 12 months is $6.00. Based on these targets, HUGE could surge 275.0% to reach the target high and rise by 275.0% to reach the target low. Reaching the average price target will result in a growth of 275.0% from current levels.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.

Leave a Comment

Your email address will not be published. Required fields are marked *